Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging

Radiology

Volumn 257, Issue 2, 2010, Pages 448-454

  Raz, Eytan ^a   Cercignani, Mara ^b   Sbardella, Emilia ^a   Totaro, Porzia ^a,c   Pozzilli, Carlo ^a   Bozzali, Marco ^b   Pantano, Patrizia ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c Istituto di Neuroscienze   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CLINICALLY ISOLATED SYNDROME; COHORT ANALYSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; GRAY MATTER; HEMISPHERE; HUMAN; INFORMED CONSENT; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; ANISOTROPY; ATROPHY; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 77958566737     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100626     Document Type: Article

References (48)

1. Noseworthy JH, Lucchinetti CF, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343(13):938-952.
2. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis:current status and future prospects. Lancet Neurol 2008;7(7):615-625.
3. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15(3):239-245. (Pubitemid 34596884)
4. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999;122(pt 1):17-26.
5. Geurts JJ, Bö L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005;26(3):572-577. (Pubitemid 43085960)
6. Zivadinov R, Minagar A. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach. J Neurol Sci 2009;282(1-2):1-4.
7. Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007;64(1):76-80. (Pubitemid 46072427)
8. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128(pt 11):2705-2712. (Pubitemid 41552953)
9. De Stefano ND, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60(7):1157-1162. (Pubitemid 36418778)
10. Spanò B, Cercignani M, Basile B, et al. Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis. Mult Scler 2010;16(2):178-188.
11. Raz E, Cercignani M, Sbardella E, et al. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010;254(1):227-234.
12. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13(3):227-231. (Pubitemid 13158528)
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58(6):840-846.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis:an expanded disability status scale (EDSS). Neurology 1983;33(11):1444-1452.
15. Simon JH, Li D, Traboulsee A, et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol 2006;27(2):455-461. (Pubitemid 44897861)
16. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-S219. (Pubitemid 39421720)
17. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 2008;71(9):632-638.
18. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5(2):143-156. (Pubitemid 35282800)
19. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxel-wise analysis of multi-subject diffusion data. Neuroimage 2006;31(4):1487-1505.
20. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44(1):83-98.
21. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26(3):839-851.
22. Tiberio M, Chard DT, Altmann DR, et al. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 2005;64(6):1001-1007. (Pubitemid 40388451)
23. Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008;64(3):255-265.
24. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127(pt 5):1101-1107.
25. Henry RG, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML, Pelletier D. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008;79(11):1236-1244.
26. Chard DT, Griffin CM, Rashid W, et al. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 2004;10(4):387-391. (Pubitemid 39117333)
27. Ceccarelli A, Rocca MA, Pagani E, et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008;42(1):315-322.
28. Traboulsee A, Dehmeshki J, Brex PA, et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 2002;59(1):126-128. (Pubitemid 34742808)
29. Audoin B, Davies GR, Finisku L, Chard DT, Thompson AJ, Miller DH. Localization of grey matter atrophy in early RRMS:a longitudinal study. J Neurol 2006;253(11):1495-1501. (Pubitemid 44950285)
30. Ge Y, Grossman RI, Udupa JK, Babb JS, Nyúl LG, Kolson DL. Brain atrophy in relapsing- remitting multiple sclerosis:fractional volumetric analysis of gray matter and white matter. Radiology 2001;220(3):606-610. (Pubitemid 32799964)
31. Tedeschi G, Lavorgna L, Russo P, et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 2005;65(2):280-285. (Pubitemid 41022375)
32. Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125(pt 2):327-337. (Pubitemid 34127435)
33. Tao G, Datta S, He R, Nelson F, Wolinsky JS, Narayana PA. Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry. J Neurol Sci 2009;282(1-2):39-46.
34. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67(6):960-967. (Pubitemid 44454585)
35. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52(5):650-653.
36. Houtchens MK, Benedict RH, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69(12):1213-1223. (Pubitemid 47429021)
37. Schmierer K, Wheeler-Kingshott CA, Boulby PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007; 35(2):467-477. (Pubitemid 46400551)
38. Ciccarelli O, Werring DJ, Barker GJ, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging:evidence of Wallerian degeneration. J Neurol 2003;250(3):287-292. (Pubitemid 36399267)
39. Cercignani M, Inglese M, Pagani E, Comi G, Filippi M. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22(5):952-958. (Pubitemid 32436241)
40. Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56(3):304-311. (Pubitemid 32144139)
41. Rashid W, Hadjiprocopis A, Griffin CM, et al. Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction. Mult Scler 2004;10(1):9-15. (Pubitemid 38100521)
42. Bammer R, Augustin M, Strasser-Fuchs S, et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med 2000;44(4):583-591.
43. Gallo A, Rovaris M, Riva R, et al. Diffusion tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 2005;62(5):803-808. (Pubitemid 40656097)
44. Cassol E, Ranjeva JP, Ibarrola D, et al. Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter. Mult Scler 2004;10(2):188-196. (Pubitemid 38499913)
45. Rovaris M, Judica E, Ceccarelli A, et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008;255(8):1209-1214.
46. Perry VH, Anthony DC. Axon damage and repair in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 1999;354(1390):1641-1647. (Pubitemid 29534431)
47. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7(9):841-851.
48. Brett M, Leff AP, Rorden C, Ashburner J. Spatial normalization of brain images with focal lesions using cost function masking. Neuroimage 2001;14(2):486-500. (Pubitemid 32709562)